AEF-0217

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameAEF-0217
Drug Alias NameAEF-0217
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsDown Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyFranceSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAelis Farma
China Registration ClassN/A

Develop Information

Active CompaniesAelis Farma
Inactive CompaniesN/A
Active IndicationsDown Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A